Patent · US Active

Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporter

US7615360B2 · kind B2 · utility

1Cited by

1References

1Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Guenter Mueller · Pocking, DE
Silke Dlugai · Düsseldorf, DE
Doerthe Voss · Düsseldorf, DE
Eckhard Boles · Dreieich, DE

Key dates

Filing date	Jul 10, 2007
Grant date	Nov 10, 2009
Priority date	—
Expiry date	Jul 10, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to yeast strains in which a human GLUT4 transport or a human GLUT1 transporter can be functionally expressed and to particular GLUT4 transport proteins which can be functionally expressed particularly readily in yeast strains.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.